WO2010056048A3 - 아릴옥시아세틸계 화합물을 유효성분으로 포함하는 dna 메틸트랜스퍼레이즈 억제용 약학적 조성물 - Google Patents

아릴옥시아세틸계 화합물을 유효성분으로 포함하는 dna 메틸트랜스퍼레이즈 억제용 약학적 조성물 Download PDF

Info

Publication number
WO2010056048A3
WO2010056048A3 PCT/KR2009/006643 KR2009006643W WO2010056048A3 WO 2010056048 A3 WO2010056048 A3 WO 2010056048A3 KR 2009006643 W KR2009006643 W KR 2009006643W WO 2010056048 A3 WO2010056048 A3 WO 2010056048A3
Authority
WO
WIPO (PCT)
Prior art keywords
aryloxyacetyl
dna
based compounds
present
pharmaceutical composition
Prior art date
Application number
PCT/KR2009/006643
Other languages
English (en)
French (fr)
Other versions
WO2010056048A2 (ko
Inventor
이경
원미선
이정준
정경숙
박성규
권병목
임남희
강정은
김영란
하연
김보연
안종석
Original Assignee
한국생명공학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국생명공학연구원 filed Critical 한국생명공학연구원
Publication of WO2010056048A2 publication Critical patent/WO2010056048A2/ko
Publication of WO2010056048A3 publication Critical patent/WO2010056048A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 화학식 1로 표시되는 아릴옥시아세틸계 화합물을 유효성분으로 함유하는 DNA 메틸렌트랜스퍼레이즈 억제용 약학적 조성물에 관한 것으로, 본 발명에 의한 조성물은 DNA 과메틸화(DNA hypermethylation)에 의해 유발되는 질환 인항종양, 뇌신경 질환, 혈액질환, 후생유전 질환의 치료제로 사용될 수 있다. 또한, 본 발명은 DNA 메틸트랜스퍼레이즈 억제제 또는 DNA 메틸레이션 억제제를 제조하기 위해 하기 화학식(1)로 표시되는 아릴옥시아세틸계 화합물 또는 이의 약학적으로 허용가능한 염을 사용하는 용도 제공한다. 본 발명은 화학식 1로 표시되는 아릴옥시아세틸계 화합물 (LW6) 또는 이의 약학적으로 허용되는 염을 DNA 메틸트랜스퍼레이즈 억제 또는 DNA 메틸레이션 억제를 필요로 하는 포유류(인간 포함)에게 투여함으로서 DNA 과메틸화에 의해 유발되는 질환을 치료하는 방법을 제공한다.
PCT/KR2009/006643 2008-11-12 2009-11-12 아릴옥시아세틸계 화합물을 유효성분으로 포함하는 dna 메틸트랜스퍼레이즈 억제용 약학적 조성물 WO2010056048A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0112141 2008-11-12
KR1020080112141A KR20100053150A (ko) 2008-11-12 2008-11-12 아릴옥시아세틸계 유도체를 유효성분으로 포함하는 ｄｎａ 메틸트렌스퍼레이즈 억제용 약학적 조성물

Publications (2)

Publication Number Publication Date
WO2010056048A2 WO2010056048A2 (ko) 2010-05-20
WO2010056048A3 true WO2010056048A3 (ko) 2010-08-26

Family

ID=42170522

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/006643 WO2010056048A2 (ko) 2008-11-12 2009-11-12 아릴옥시아세틸계 화합물을 유효성분으로 포함하는 dna 메틸트랜스퍼레이즈 억제용 약학적 조성물

Country Status (2)

Country Link
KR (1) KR20100053150A (ko)
WO (1) WO2010056048A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101380466B1 (ko) * 2011-09-27 2014-04-02 한국생명공학연구원 ＨＩＦ―１α 활성을 저해하는 신규 화합물 및 그 제조방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020060991A (ko) * 1999-12-09 2002-07-19 아스트라제네카 아베 아다만탄 유도체
KR20050101559A (ko) * 2003-02-21 2005-10-24 아스트라제네카 아베 아다만탄 유도체, 이의 제조 방법 및 이를 함유하는 제약조성물
KR100787131B1 (ko) * 2006-07-04 2007-12-21 한국생명공학연구원 Ｈｉｆ―１ 활성을 저해하는 화합물, 이의 제조방법 및이를 유효성분으로 함유하는 약학적 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020060991A (ko) * 1999-12-09 2002-07-19 아스트라제네카 아베 아다만탄 유도체
KR20050101559A (ko) * 2003-02-21 2005-10-24 아스트라제네카 아베 아다만탄 유도체, 이의 제조 방법 및 이를 함유하는 제약조성물
KR100787131B1 (ko) * 2006-07-04 2007-12-21 한국생명공학연구원 Ｈｉｆ―１ 활성을 저해하는 화합물, 이의 제조방법 및이를 유효성분으로 함유하는 약학적 조성물

Also Published As

Publication number Publication date
KR20100053150A (ko) 2010-05-20
WO2010056048A2 (ko) 2010-05-20

Similar Documents

Publication Publication Date Title
WO2010022055A3 (en) 1, 3, 5 -triaz ine derivatives useful in the treatment of chronic pain disorders
MX2009004745A (es) Derivados de 1,2,3-triazol como inhibidores del receptor sigma.
EP2650293A8 (en) [1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof
WO2006067445A3 (en) Csf-1r kinase inhibitors
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
EA201000552A1 (ru) Производные пирроло[2,3-d]пиримидина в качестве ингибиторов протеинкиназы в
EA200900733A1 (ru) ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНА, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ НАРУШЕНИЙ И БОЛЕЗНЕЙ, СВЯЗАННЫХ С АНГИОГЕНЕЗОМ
GEP20125459B (en) Compounds for inhibiting mitotic progression
MXPA04012965A (es) Inhibidores virales.
UA86614C2 (ru) Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата
WO2009155121A3 (en) Inhibitors of pi3 kinase
DE602004007239D1 (de) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN
WO2008005956A3 (en) Pyrrolotriazine kinase inhibitors
BR112015015477A2 (pt) derivados de 2,3-di-hidro-isoindol-1-ona e métodos de uso dos mesmos como inibidores de btk
WO2009030952A3 (en) Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway
MX2010006748A (es) Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2.
WO2007092936A3 (en) Method to treat gastric lesions
WO2007064932A3 (en) Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
WO2008023258A8 (en) Piperidine derivatives
WO2006116733A3 (en) Protein kinase inhibitors
MY150075A (en) Novel phosphodiesterase inhibitors
GB0112348D0 (en) Compounds
TW200745136A (en) 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
WO2012064897A3 (en) Bicyclic and tricyclic inhibitors of sumoylation enzymes and methods for their use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09826280

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09826280

Country of ref document: EP

Kind code of ref document: A2